REQUEST A DEMO
Total
USD $0.00
Search more companies

Medidata Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Medidata Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Manufacturing, trading and supply in healthcare and pharmaceuticals products; providing all kinds of services relating to information technology (it) products; general trading and services, distributors, importers, exporters, factors and shippers of wholesale, retail dealers in goods and liquefied petroleum gas (lpg)

Headquarters
36 Jalan Pjs 8/6, Sunway Mentari
Petaling Jaya; Selangor; Postal Code: 46150

Contact Details: Purchase the Medidata Sdn. Bhd. report to view the information.

Website: http://www.medidata.com.my

Basic Information
Outstanding Shares:
Purchase the Medidata Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Medidata Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Medidata Sdn. Bhd. report to view the information.
Incorporation Date:
July 12, 1977
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Subsidiaries
Medidata Pharmaceuticals Sdn. Bhd.
70%
Company Performance
Financial values in the chart are available after Medidata Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-51.69%
Total operating revenue
-51.69%
Operating profit (EBIT)
-94.32%
EBITDA
-66.92%
Net Profit (Loss) for the Period
N/A
Total assets
7.81%
Total equity
-0.37%
Operating Profit Margin (ROS)
-9.24%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
5.4%
Quick Ratio
-1.57%
Cash Ratio
-0.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?